Gene: DNLZ
Official Full Name: DNL-type zinc fingerprovided by HGNC
Gene Summary: Enables protein folding chaperone. Involved in chaperone-mediated protein complex assembly. Located in nucleoplasm. Is active in cytosol; mitochondrion; and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18197 | DNLZ Knockout cell line (HeLa) | Human | DNLZ | 1:3~1:6 | Negative | Online Inquiry |
KO18198 | DNLZ Knockout cell line (HCT 116) | Human | DNLZ | 1:2~1:4 | Negative | Online Inquiry |
KO18199 | DNLZ Knockout cell line (HEK293) | Human | DNLZ | 1:3~1:6 | Negative | Online Inquiry |
KO18200 | DNLZ Knockout cell line (A549) | Human | DNLZ | 1:3~1:4 | Negative | Online Inquiry |
DNLZ Gene Knockout Cell Lines are a powerful tool in molecular biology research, specifically designed to facilitate the study of gene function and the impact of specific genetic alterations on cellular processes. These cell lines are engineered using CRISPR/Cas9 technology to create homozygous deletions in the DNLZ gene, providing a precise and reliable model for elucidating the role of this gene in various biological contexts.
The key function of DNLZ Gene Knockout Cell Lines lies in their ability to enable researchers to investigate the biochemical pathways and cellular mechanisms that are influenced by the loss of DNLZ expression. By utilizing these knockout models, scientists can explore gene-editing applications such as assessing alterations in signal transduction, cell proliferation, and differentiation. This technology generates reproducible results that are critical in advancing our understanding of diseases, including cancer and neurodegenerative disorders.
The scientific importance of DNLZ Gene Knockout Cell Lines transcends basic research; they also have valuable applications in clinical settings. For instance, these cell lines can serve as a platform for drug screening, allowing for the identification of therapeutic compounds that can target pathways modulated by DNLZ. Furthermore, they can be used to assess the effects of gene therapy approaches aimed at correcting genetic defects, thereby offering insights into potential treatment strategies.
Compared to traditional knockout models, which may be time-consuming and less specific, DNLZ Gene Knockout Cell Lines offer a faster turnaround time and a higher level of precision. The ease of generating DNLZ knockouts allows researchers to focus on experimental design and hypothesis testing, significantly enhancing productivity. Additionally, our cell lines are validated for consistent performance across various experimental conditions, ensuring reliable outcomes and reproducibility.
Choosing DNLZ Gene Knockout Cell Lines empowers researchers and clinicians to push the boundaries of genetic research, paving the way for innovative discoveries and advancements in therapeutic strategies. This product is supported by our extensive expertise in gene editing technologies and a commitment to providing high-quality biological research tools. Our dedicated team is available to assist users in maximizing the value derived from our innovative offerings, reinforcing the potential of genetic research in addressing complex biological challenges.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.